Exencial Wealth Advisors' David Yepez expects another profitable quarter from Tesla Wednesday that could clear the way for it to join the S&P 500. He also tells Reuters' Fred Katayama investors should snap up shares of Akamai and Sanofi on a market pullback.
French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.
waseem Ahmed Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/y2EZbIidyV 6 hours ago
B2Cpromo Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/2izJHgRq9d https://t.co/kuP1ullIan 8 hours ago
The Real News pro! Sanofi lifts earnings view as Regeneron stake sale boosts Q2 106637256 8 hours ago
Markets Today#Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/OE9awEuV3n 9 hours ago
TheLocalBusinessPod Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/Og1uo9wBTL https://t.co/4JfAX3Uj5j 9 hours ago
STCK.PRO $REGN $SNY NEW ARTICLE : Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/F4YqVnydcQ Get a… https://t.co/I1sJeBikog 9 hours ago
CNBC International Sanofi lifts earnings view as Regeneron stake sale boosts Q2 https://t.co/DabjGFJnkC 9 hours ago